Department of Urology

VUMC Patient Navigator Bri Yip, at left, reviews upcoming prenatal appointments with MyMaternityHealth Bundle participant Amy New.

New MyHealth Bundles to help treat kidney stones, substance use disorder

Employees covered by Vanderbilt University Medical Center health plans and employees covered by the Metro Nashville Public Schools health plan can now enroll in two new MyHealth Bundles: MyUrologyHealth for the treatment of kidney stones and MyRecoveryHealth for the treatment of substance use disorder.

E. coli uses serine to abide acidity

Vanderbilt researchers have discovered another acid resistance mechanism for UTI-causing E. coli, laying the foundation for targeted antibacterial therapies.

Mark Cuban pharmacy could save billions on prostate cancer, bladder drugs

Vanderbilt research found that a new drug company founded by entrepreneur Mark Cuban could save patients $1.29 billion a year based on 2020 Medicare Part D expenditures on just the nine most popular urological drugs.

Study reveals pathways for aggressive prostate cancer subtype

Research from Vanderbilt-Ingram Cancer Center has revealed new information about the molecular pathways of cribriform prostate cancer.

Gender differences with bladder pain

Gender differences in the pain experiences and treatment needs of people with a urologic pain syndrome could be used to improve interventions, Vanderbilt researchers report.

Maria Hadjifrangiskou, PhD, Connor Beebout, PhD, and colleagues are studying why the bacterium E. coli is so tenacious.

Study describes how E. coli co-opts cells, causes recurrent UTIs

Researchers at Vanderbilt University Medical Center have discovered why the uropathogenic bacterium E. coli, the leading cause of urinary tract infections, is so tenacious; their findings could lead to new ways to prevent recurrent UTIs.

1 2 3 4 5 9